Tag: Recce Pharmaceuticals
Recce Pharmaceuticals: Secures patent from E.U. regulator
Recce Pharmaceuticals (RCE) has secured a patent from the European regulator covering two of its synthetic anti-infective formulations
This is the second time...
Recce Pharmaceuticals: Completes $27.95M capital raise
Recce Pharmaceuticals (RCE) has completed its capital raise and successfully raised $27.95 million
All up, 21.5 million fully paid ordinary shares will now...
Recce Pharmaceuticals: Appoints new CEO
Recce Pharmaceuticals (RCE) Board of Directors has unanimously appointed James Graham as the company’s new CEO
James has served as Recce’s Executive Director...